Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharat Thongprayoonen_US
dc.contributor.authorNadeen J. Khouryen_US
dc.contributor.authorTarun Bathinien_US
dc.contributor.authorNarothama Reddy Aeddulaen_US
dc.contributor.authorBoonphiphop Boonphengen_US
dc.contributor.authorPloypin Lertjitbanjongen_US
dc.contributor.authorKanramon Watthanasuntornen_US
dc.contributor.authorNapat Leeaphornen_US
dc.contributor.authorSupavit Chesdachaien_US
dc.contributor.authorAldo Torres-Ortizen_US
dc.contributor.authorWisit Kaewputen_US
dc.contributor.authorJackrapong Bruminhenten_US
dc.contributor.authorMichael A. Maoen_US
dc.contributor.authorWisit Cheungpasitpornen_US
dc.contributor.otherUniversity of Minnesota Twin Citiesen_US
dc.contributor.otherUMKC School of Medicineen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThe University of Arizonaen_US
dc.contributor.otherIndiana University School of Medicine-Evansvilleen_US
dc.contributor.otherHenry Ford Hospitalen_US
dc.contributor.otherMayo Clinicen_US
dc.contributor.otherUniversity of Mississippi Medical Centeren_US
dc.contributor.otherThe Mary Imogene Bassett Hospitalen_US
dc.contributor.otherMayo Clinic in Jacksonville, Floridaen_US
dc.contributor.otherEast Tennessee State Universityen_US
dc.identifier.citationUrology Annals. Vol.12, No.3 (2020), 241-247en_US
dc.description.abstract© 2020 Urology Annals | Published by Wolters Kluwer-Medknow. Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.en_US
dc.rightsMahidol Universityen_US
dc.titleEpidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysisen_US
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.